Retroviral Integration Site Analysis in Hematopoietic Stem Cells
Authors:
- 1 January 2008
- book chapter
- Published by Springer Nature
- Vol. 430, 255-267
Abstract
Stable transgene insertion into a host genome irrevocably and unambiguously marks individual cells and all their descendants, i.e., the respective cell clone. Based thereon, retroviral gene marking has become an important tool for investigating the in vivo fate of different cell types, both in animal models and in clinical gene transfer. Moreover, identification of (vector) insertion sites in malignant clones transformed because of insertional activation of proto-oncogenes after experimental as well as therapeutic retroviral gene transfer has resulted in new insights into oncogenic transformation of hematopoietic stem cells (HSCs). However, because of the high sensitivity of the PCR-based methods for insertion site detection, researchers are often confronted with large numbers of different insertion sites/cell clones whose contribution to the given state is hard to judge. A relatively simple ligation-mediated polymerase chain reaction (LM-PCR) method allows the preferential analysis of insertion sites in those cell clones that significantly contributed to the cell pool analyzed. In murine bone marrow transplantation models, we have shown that this method is very useful to analyze the impact of retroviral insertion sites on both malignant and benign clonal dominance of individual repopulating HSC.Keywords
This publication has 14 references indexed in Scilit:
- Retrovirus Vectors: Toward the Plentivirus?Molecular Therapy, 2006
- Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaqueBlood, 2006
- Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Nature Medicine, 2006
- Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene MarkingScience, 2005
- Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trialBlood, 2005
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonatesNature Medicine, 2003
- Evidence that the number of hematopoietic stem cells per animal is conserved in mammalsBlood, 2002
- Murine Leukemia Induced by Retroviral Gene MarkingScience, 2002
- Genomic Sequencing and Methylation Analysis by Ligation Mediated PCRScience, 1989